Under the same experimental format as Figure 1e left column, except using a molar ratio of GSSSG and LASSS to HGF (1:8000), LASSS-treated HGF (Figure 1e right column, bar 9 ) displayed about 2-fold higher c-met binding than the control HGF level ( bar 8 , in which HGF just received the solvent) equivalent to the positive controls ( bars 2 and 2 in the left column)
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Subcutaneous Protocol (4 mL = 12.5 mg/mL) Frequency: Inject once or twice daily subcutaneously
Supports visible improvements in skin tone, texture and overall appearance with consistent daily use
Dark Spot Reduction It also targets melanin accumulation in specific parts of the body, for instance, sun spots, dark spots, melasma, and acne marks
*Skin Renewal & Anti-Aging: Stimulates collagen production, helping to reduce wrinkles, fine lines, and age spots
Marconi, G